Health Catalyst, Inc. (HCAT)
1.51
+0.15
(+11.03%)
USD |
NASDAQ |
Nov 13, 16:00
1.50
-0.01
(-0.66%)
After-Hours: 19:59
Health Catalyst EPS Diluted (Quarterly) : 0.5333 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.5333 |
| June 30, 2026 | -0.5481 |
| March 31, 2026 | -1.529 |
| December 31, 2025 | -1.282 |
| September 30, 2025 | -0.3159 |
| June 30, 2025 | -0.5886 |
| March 31, 2025 | -0.3463 |
| December 31, 2024 | -0.3314 |
| September 30, 2024 | -0.2436 |
| June 30, 2024 | -0.2279 |
| March 31, 2024 | -0.3514 |
| December 31, 2023 | -0.5274 |
| September 30, 2023 | -0.3885 |
| June 30, 2023 | -0.5826 |
| March 31, 2023 | -0.5982 |
| December 31, 2022 | -0.6566 |
| September 30, 2022 | -0.8422 |
| June 30, 2022 | -0.6228 |
| March 31, 2022 | -0.5367 |
| December 31, 2021 | -0.94 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.8166 |
| June 30, 2021 | -0.7983 |
| March 31, 2021 | -0.6467 |
| December 31, 2020 | -1.010 |
| September 30, 2020 | -0.6782 |
| June 30, 2020 | -0.7129 |
| March 31, 2020 | -0.4713 |
| December 31, 2019 | -0.3906 |
| September 30, 2019 | -1.403 |
| June 30, 2019 | -2.996 |
| March 31, 2019 | -2.13 |
| December 31, 2018 | -0.372 |
| September 30, 2018 | -0.4765 |
| June 30, 2018 | -0.4726 |
| March 31, 2018 | -0.0474 |
| December 31, 2017 | -0.1919 |
| September 30, 2017 | -0.3666 |
| June 30, 2017 | -0.3585 |
| March 31, 2017 | -0.3718 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| LataMed AI Corp. | -0.0003 |
| SCWorx Corp. | -1.355 |
| GoodRx Holdings, Inc. | 0.0245 |
| Claritev Corp. | -3.64 |
| iSpecimen, Inc. | -0.9773 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 40.50M |
| Revenue (Quarterly) | 56.28M |
| Total Expenses (Quarterly) | 15.79M |
| Enterprise Value | 51.76M |
| Gross Profit Margin (Quarterly) | 25.67% |
| Profit Margin (Quarterly) | 71.95% |
| Earnings Yield | -187.2% |
| Normalized Earnings Yield | -44.41 |